Last update :
28/04/2024
Anticancer drug   Cytarabine  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alexan Austria, Chile, Colombia, Egypt, Germany, Hungary, Luxembourg, Netherlands, Republic of South Africa, Russian, Saudi Arabia, Thailand, Turkey, United Arab Emirates
Alexane Iran
Ara Cell Germany, Portugal
Arabine Denmark, Finland, Iceland, Sweden
Aracytin Brazil, Chile, Colombia, Egypt, Greece, Italy
Aracytine Colombia, France, Morocco
Cancyt India
Citab Brazil
Citarabina Argentina, Chile, Colombia, Ecuador, Italy, Mexico, Spain
Cylocide Japan
Cytaban Colombia
Cytaloxan Portugal
Cytarabine Australia, Belgium, Canada, Denmark, Egypt, Finland, Great Britain, Ireland, Malaysia, New Zealand, United Arab Emirates, United States of America
Cytarax Brazil, Mexico
Cytonal Turkey
Cytosafe Great Britain
Cytosar Austria, Belgium, Canada, Croatia, Denmark, Hungary, Iran, Ireland, Luxembourg, Malaysia, Netherlands, Norway, Poland, Portugal, Republic of South Africa, Saudi Arabia, Switzerland, United Arab Emirates, Venezuela
Ifarab Mexico
Laracit Chile, Colombia, Mexico
Medsara Mexico
Novutrax Colombia, Mexico
Oncorab Venezuela
Tabine Ecuador
Udicil Germany
Zuphacit Mexico

Factors which affect stability   Injection   Factors which affect stability : Cytarabine        
References
Solvent Glucose 5% Induces Reduced stability 2255
Solvent Parenteral nutrition (binary mixture) Induces Degradation 301
Temperature 25°C Induces Reduced stability 4455

  Mentions Légales